[ Dividend Alert ] These 5 Stocks Need to be on Your Watchlist
March 6, 2024
Editorial Insights
Dear Reader,
Discover upcoming ex-dividend stocks for potential dividends. Buying a stock on or after its ex-dividend date means missing the next dividend—sellers receive it. Purchase before the ex-dividend date to secure the dividend. Selling before the ex-dividend date forfeits your right to the stock dividend. Stay mindful.
Explore our latest Dividend Report below:
Novartis AG
Ticker: NVS
Recent Price: $102.10
Average Analyst Price Target: $113.67 (11.33%)
Market Cap: $208.70B
Last Dividend Amount: $2.46
Expected Ex-Dividend Date: Mar 07 2024
Expected Payment Date: Mar 07 2024
Expected Dividend & Yield: 3.70%
Summary: Novartis has one of the strongest and broadest portfolio of oncology drugs and generics. It continues to build depth in 5 core therapeutic areas Cardio-Renal, Immunology, Neuroscience, Oncology and Hematology, strength in technology platforms - Targeted Protein Degradation, Cell Therapy, Gene Therapy, Radioligand Therapy, and xRNA. Novartis efforts to strengthen its wide and deep oncology portfolio by developing breakthrough treatments. Cosentyx, Entresto, Kesimpta, Zolgensma, Kisqali and Leqvio. In March 2015, Novartis acquired certain oncology products and pipeline compounds from Glaxo. In exchange, it sold its non-influenza Vaccines business to Glaxo. Also, the company has spun off the Alcon business into a separate company. In January 2015, Novartis divested its Animal Health division to Lilly. In July 2015, the company divested its influenza vaccines business to CSL Limited. Novartis has also acquired The Medicines Company, adding Leqvio, to its portfolio. Novartis sold its investment in Roche.
Recent Analyst Action: Steve Scala, analyst at TD Cowen, reiterates coverage on Novartis AG (NVS) in the Healthcare sector with a Hold rating (2 days ago).
Here are 3rd party ratings for NVS:
TipRanks.com: Hold
TradingView.com: Buy
Yahoo! Finance: Bullish Short-Term Outlook
Barchart.com: buy
Zacks.com: Hold, Bottom 33% (168 out of 252)
--------------------------------------------------------------------------
Sponsor Ad
#1 Stock for Energy Crisis (Buy Now for Just $8)
As the world suffers an oil shock… And gas prices rip higher…
One tiny company could have the answer to the global energy crisis.
It’s using AI to crack open the largest untapped energy source on the planet… 5X larger than the biggest oil field on Earth.
Act fast, this $8 stock could be moments away from appreciating considerably.
Elevance Health Inc.
Ticker: ELV
Recent Price: $498.35
Average Analyst Price Target: $586.80 (17.75%)
Market Cap: $115.95B
Last Dividend Amount: $1.63
Expected Ex-Dividend Date: Mar 07 2024
Expected Payment Date: Mar 22 2024
Expected Dividend & Yield: 1.31%
Summary: Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana.
Recent Analyst Action: Steven Valiquette, analyst at Barclays, reiterates coverage on Elevance Health Inc. (ELV) in the Healthcare sector with a Buy rating and a price target of $584 (1 day ago).
Here are 3rd party ratings for ELV:
TipRanks.com: Buy
TradingView.com: Buy
Yahoo! Finance: Neutral Short-Term Outlook
Barchart.com: Strong buy
Zacks.com: Buy, Top 27% (69 out of 252)
--------------------------------------------------------------------------
Simon Property Group, Inc.
Ticker: SPG
Recent Price: $149.86
Average Analyst Price Target: $156.60 (4.50%)
Market Cap: $48.84B
Last Dividend Amount: $1.95
Expected Ex-Dividend Date: Mar 07 2024
Expected Payment Date: Mar 29 2024
Expected Dividend & Yield: 5.20%
Summary: Simon Property Group Inc. is a leading publicly-traded real estate investment trust in the United States, which is engaged in acquiring, owning and leasing of shopping, dining, entertainment and mixed-use destinations. The company's real estate portfolio consists of malls, Premium Outlets and The Mills and International Properties. Simon Property owns or holds interests in properties in the United States. This consist of malls, Premium Outlets, Mills, lifestyle centers and other retail properties in the states and Puerto Rico.
Recent Analyst Action: Steve Sakwa, analyst at Evercore ISI, reiterates coverage on Simon Property Group, Inc. (SPG) in the Real Estate sector with a Hold rating and a price target of $150 (1 week ago).
Here are 3rd party ratings for SPG:
TipRanks.com: Hold
TradingView.com: Strong Buy
Yahoo! Finance: Neutral Short-Term Outlook
Barchart.com: Strong buy
Zacks.com: Hold, Top 37% (92 out of 252)
--------------------------------------------------------------------------
Sponsor Ad
GPT-4 vs. X.AI: The Race of the New AI Giants
The smart money investors all know AI is the wave of the future and could mean huge profits for anyone involved.
AI has been called the biggest new industry of the 21st century. Experts are projecting it will be worth a staggering $80 trillion over the next 10 years.
And right now, Chief Investment Strategist Adam O’Dell is revealing his favorite X.AI stock you should check out today.
Click here to see the full story now.
WesBanco, Inc.
Ticker: WSBC
Recent Price: $29.73
Average Analyst Price Target: $32.80 (10.33%)
Market Cap: $1.77B
Last Dividend Amount: $0.36
Expected Ex-Dividend Date: Mar 07 2024
Expected Payment Date: Apr 01 2024
Expected Dividend & Yield: 4.84%
Summary: WESBANCO, INC. is a multi-bank holding company whose subsidiaries are engaged in general banking business.
Recent Analyst Action: Casey Whitman, analyst at Piper Sandler, reiterates coverage on WesBanco, Inc. (WSBC) in the Financial Services sector with a Hold rating and a price target of $32 (1 month ago).
Here are 3rd party ratings for WSBC:
TipRanks.com: Hold
TradingView.com: Strong Buy
Yahoo! Finance: Bearish Short-Term Outlook
Barchart.com: Strong buy
Zacks.com: Hold, Top 26% (66 out of 252)
--------------------------------------------------------------------------
DRDGOLD Limited
Ticker: DRD
Recent Price: $7.58
Average Analyst Price Target: $13.25 (74.80%)
Market Cap: $653.02M
Last Dividend Amount: $0.08
Expected Ex-Dividend Date: Mar 07 2024
Expected Payment Date: Mar 21 2024
Expected Dividend & Yield: 5.94%
Summary: DRDGOLD is a medium-sized, unhedged gold producer with investments in South Africa and Australasia. Incontrovertibly bullish about its product, the company has recently concluded extensive refocusing of its gold interests.
Recent Analyst Action: Heiko Ihle, analyst at H.C. Wainwright, reiterates coverage on DRDGOLD Limited (DRD) in the Basic Materials sector with a Buy rating and a price target of $13.25 (2 weeks ago).
Here are 3rd party ratings for DRD:
TipRanks.com: Buy
TradingView.com: Buy
Yahoo! Finance: Bullish Short-Term Outlook
Barchart.com: sell
Zacks.com: Buy, Bottom 44% (141 out of 252)
--------------------------------------------------------------------------
Sponsor Ad
Digital Dollar: Freedom or Financial Slavery?
Is a digital dollar really America’s way to financial freedom?
Or is it the start of a wave of financial servitude?
Get the details on the potential risks of a digital dollar and what you can do to protect yourself.
From privacy concerns to economic control, protect yourself with this free guide.
Escape the digital dollar with this free guide
And there you have it.
For inquiries regarding specific dividends, we recommend consulting with your financial advisor or visiting Investor.gov for more comprehensive information.
Best regards,
The Editor